Epidemiological profile of candidiasis in HIV/AIDS patients in a tertiary care hospital

Authors

  • Megh S. Dhakad Department of Microbiology, Lady Hardinge Medical Collegel, New Delhi, India
  • Ravinder Kaur Department of Microbiology, Lady Hardinge Medical Collegel, New Delhi, India
  • Ritu Goyal Department of Obstetrics & Gynaecology, Vardman Mahavir Medical College & Safdarjung Hospital New Delhi, India
  • Preena Bhalla Department of Microbiology, North DMC Medical College & Hindu Rao Hospital, Delhi, India
  • Richa Dewan Department of Medicine, Maulana Azad Medical College, New Delhi, India

DOI:

https://doi.org/10.18203/2394-6040.ijcmph20205153

Keywords:

HIV, Candidiasis, Epidemiology, AIDS, CD4 - count

Abstract

Background: Clinical research in fungal infections is largely a neglected area in health care settings in India. Candida species cause diseases ranging from mucosal infections to systemic mycoses depending on host’s immune status. Aim of this study was to evaluate the clinico-epidemiological profile of candidiasis, and their correlation with an immunological profile in HIV/AIDS patients.

Methods: Clinical details and investigations of 200 symptomatic, confirmed HIV-positive patients, suspected of having candidiasis were recorded and analyzed. Relevant clinical samples depending on the organ system involved were collected and subjected to direct microscopy, culture isolation and serology. Identification and speciation of the isolates was done by biochemical methods as per standard recommended procedures. CD4-count was determined by flow cytometry using Fluorescent Activated Cell Sorter Count system.

Results: Patients ranged from 17-65 years with a mean age of 33.83±9.07 years. Most common clinical presentations were seen to be white oral patches (82%), weight loss (79%), fever (67%), loss of appetite (53%), headache (51.5%), cough (38.5%) and diarrhea (30%).  Gastrointestinal system (35%) was the most commonly involved system. The CD4-counts ranged from 16-1033 cells/μl. 93 (46.5%) patients had CD4-counts <200 cells/μl, while CD4-count <100 cells/μl was seen in 40 (20%) and CD4-count <50 cells/μl in 20 (10%). Candidiasis was detected in 60% of the patients. Yeasts isolated were C. albicans (82.51%), C. tropicalis (6.29%), C. krusei (4.89%), C. parapsilosis (3.49%), and C. glabrata (2.79%).

Conclusions: C. albicans was predominant species and presence of oral candidiasis is a matter of concern. Early and accurate diagnosis of candidiasis is one of the keys helps for the success of effective HIV/AIDS disease management.

 

References

Marol S, Yucesoy M. Molecular epidemiology of Candida species isolated from clinical specimens of intensive care unit patients. Mycos. 2007;51:40-9.

Bongomin F, Gago S, Oladele RO, Denning DW. Global and Multi-National Prevalence of Fungal Diseases—Estimate Precision. J Fungi (Bas). 2017;3(4):57.

World Health Organization. Global update on HIV treatment 2013: results, impact and opportunities. WHO report in partnership with UNICEF and UNAIDS. 2013. Available at: http://www.unaids.org/en/media/unaids/contentassets/documents/unaidspublication/2013/20130630_treatment_report_en.pdf. Accessed on 20 May 2020.

Samaranayake LP, Cao BY, Wan J. Invitro proteinase production by oral Candida albicans isolates from individuals with and without HIV infection and its attenuation by antimycotic agents. J Med Microbiol. 1996;44:311-6.

Anwar KP, Malik A, Subhan KH. Profile of candidiasis in HIV infected patients. Iran J Microbio. 2012;4(4):204-9.

Wozniak KL, Leigh JE, Hager S, Swoboda RK, Fidel Jr PL. A Comprehensive Study of Candida-Specific Antibodies in the Saliva of Human Immunodeficiency Virus–Positive Individuals with Oropharyngeal Candidiasis. The J Infect Dis. 2002;185:1269-76.

Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high risk patients as the initial manifestation of the AIDS. N Engl Med. 1984;311:354-8.

Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309-17.

Milne LJR. Fungi in Mackie & McCartney Practical Medical Microbiology 14TH Ed. Edinburgh: Church Livingst. 1999;695-717.

Forbes BA, Sahm DF and Weissfeld AS. Laboratory Methods in Basic Mycology in Bailey and Scott’s Diagnostic Microbiology 11th EdSt. Louis: Mosby; 2002;711-98.

Winn WC. Koneman’s color Atlas and Textbook of Diagnostic Microbiology. E. W. Koneman, 6th Ed. Phiadelphia: Lipincott Williams & Wilkins. 2006: 1153-232.

Moore GS, Jaciow DM. Mycology for the clinical Laboratory. Restn, Virginia. Reston Publishing Company; 1979.

Umesh SJ, Deepali SD, Rajesh NL, Sonali GC, Vilas RM, Harshada HU. Sociodemographic and clinical profile of HIV/AIDS patients visiting to ART Centre at a rural tertiary care hospital in Maharashtra state of India. Int J Biol Med Res. 2012;3(2):1568-72.

Kumar R, Jha P, Arora P, Mony P, Bhatia P, Milson P, el al. Trends in HIV-1 in young adults in South India from 2000 to 2004: a prevalence study. Lanc. 2006:367;1164-72.

Vyas N, Saroj H, Parul S, Anuj M, Anita S, Leeta V. Prevalence of HIV/AIDS and prediction of future Trends in North west Region of India: A six year ICTC base study. Ind J Commun Medic. 2009;34(3):212-7.

Mahajan A, Tandon VR, Kumar S, Kudyar RP, Sharma A, Singh K. HIV/AIDS in families. JK Sci. 2008;10(3):124-6.

Marfatia YS, Archana S, Divyesh MA. Clinico Epidemiological study of HIV in females. Ind J Sex Transm Dis. 2004;25(2):74.

Mir MA, Sofi FA, Ahmad SN, Dar MR. Clinical and demographic profile of HIV/AIDS patients diagnosed at a tertiary care centre in Kashmir. J Pakist Medic Assoc. 2010:60(6):428-31.

Sehgal S. HIV epidemic in Punjab, India: time trends over a decade. Bulletin of the World Health Organization. 1998;76(5):509-13.

Singh A, Vairy I, Shivananda PG. Spectrum of opportunistic Infections in AIDS cases. Ind J Med Sci. 2003;57:16-21.

Malani PN, Bradley SF, Little RS, Kauffman CA. Trends in species causing fungaemia in a tertiary care medical centre over 12 years. Mycos. 2001;44:446-9.

Parisa B, Abdolvahab A, Mohammad AD, Elaheh S. Distributions and Antifungal Susceptibility of Candida Species from Mucosal Sites in HIV Positive Patients. Arch of Iran Medic. 2010;13(4):282-7.

Kothari K, Goyal S. Clinical profile of AIDS. J Assoc Physic Ind. 2001;49:435-8.

Gazzard BG. HIV disease and the gastroenterologist. Gut. 1988;29:1497-505.

Kallol S, Rushna F, Poonam S, Jyotirmoy P, Arnab R, Mihir KB, et al. Recent pattern of Co-infection amongst HIV sero-positive individuals in tertiary care hospital, Kolkata. Virol J. 2011;8:116.

Varagas KG, Sophie J. Carriage frequency, intensity of carriage, and strains of oral yeast species vary in the progression to oral candidiasis in human immunodeficiency virus-positive individuals. J Clin Microbiol. 2002;40:341-50.

Maurya V, Srivastava A, Mishra J, Gaind R, Marak RS, Tripathi AK, et al. Oropharyngeal candidiasis and Candida colonization in HIV positive patients in northern India. J Infect Dev Ctries. 2013;7(8):608-13.

Mulu A, Kassu A, Anagaw B, Moges B, Gelaw A, Alemayehu M, et al. Frequent detection of ‘azole’ resistant Candida species among late presenting AIDS patients in northwest Ethiopia. Brit Med Cent Infect Diseas. 2013;13:82.

Thesus TJ, Jeeja MC, Jayakrishna T. The Functional status of patients with AIDS attending antiretroviral treatment center. Ind J Palliat Care. 2009:15(1):57-60.

Poudel BN, Dhungana GP. Scenario of HIV/AIDS patients in a government hospital of Nepal. J Nepal Health Res Counc. 2010;8(2):103-6.

Jabra-Rizk MA, Falkler WF Jr, Merz WG, Baqui AAMA, Kelley JI, Meiller TF. Cell surface hydrophobicity-associated adherence of Candida dubliniensis to human buccal epithelial cells. Rev Iberam Micol. 2001;18:17-22.

Enwuru CA, Ogunledun A, Idika N, Enwuru NV, Ogbonna F, Aniedobe M, et al. Fluconazole resistant opportunistic oropharyngeal candida and non-candida yeast-like isolates from HIV infected patients attending ARV clinics in Lagos, Nigeria. Afr Health Sci. 2008;8:142-8.

Deorukhkar S, Saini S. Virulence Markers and Antifungal Susceptibility Profile of Candida glabrata: An Emerging Pathogen. Brit Microbiol Res J. 2014;4(1):39-49.

Jha BJ, Dey S, Tamang MD, Joshy ME, Shivananda PG, Brahmadatan KN. Characterization of Candida species isolated from cases of lower respiratory tract infection. 2006;4(3):290-4.

Marukutira T, Huprikar S, Azie N, Quan SP. Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study. HIV/AIDS- Resear Palliat Ca. 2014;6:39-47.

Pahwa N, Kumar RS, Nirkhiwale S, Bandi A. Species distribution and drug susceptibility of candida in clinical isolates from a tertiary care centre at Indore. Ind J Medic Microbiol. 2014;32(1):44-8.

Downloads

Published

2020-11-25

How to Cite

Dhakad, M. S., Kaur, R., Goyal, R., Bhalla, P., & Dewan, R. (2020). Epidemiological profile of candidiasis in HIV/AIDS patients in a tertiary care hospital. International Journal Of Community Medicine And Public Health, 7(12), 4858–4864. https://doi.org/10.18203/2394-6040.ijcmph20205153

Issue

Section

Original Research Articles